Posted in

Tansy (Tanacetum vulgare)

Nomenclature & Taxonomic Classification

  • Botanical Binomial: Tanacetum vulgare L.
  • Family: Asteraceae
  • Common Name(s): Tansy, Common Tansy, Bitter Buttons, Hindheel
  • Parts Used: Dried aerial parts and flowers.

Botanical Description, Habitat & Sustainability

  • Physical Description: * Growth Habit: Erect, rhizomatous perennial herbaceous plant.
    • Morphology: Grows 50–150 cm tall with smooth, slightly reddish stems. Leaves are alternate, deeply pinnately lobed into narrow, serrated segments, emitting a strong, camphoraceous scent. Flowers are small, button-like, bright yellow, lacking conspicuous ray florets, born in dense terminal corymbs.
  • Habitat & Cultivation: Native to temperate Europe and Asia; widely naturalized in North America. Thrives in disturbed soils, roadsides, fields, and riverbanks.
  • Sustainability Status: Secure / Considered a noxious, invasive weed in several North American regions.

Energetics & Traditional Actions

  • Western Tissue States: Corrects Depression/Torpor (highly stimulating, aromatic alterative) and Cold/Stagnation.
  • Traditional Vector:
    • Ayurveda: Rasa (Taste): Tikta (Bitter), Katu (Pungent) | Virya (Energy): Ushna (Heating) | Vipaka (Post-Digestive Effect): Katu | Dosha Modulation: Reduces Kapha and Vata; sharply increases Pitta.
    • Traditional Chinese Medicine: Temperature: Warm | Taste: Bitter, Pungent | Organ Meridians Entered: Spleen, Liver, Large Intestine.
  • Historical Folk Use: Historically utilized as a powerful anthelmintic (to expel roundworms and threadworms), a potent emmenagogue to initiate delayed menses, and externally as an insect repellent and joint wash.

Phytochemistry & Pharmacological Dynamics

  • Primary Phytochemicals: Volatile oil (containing variable percentages of $\beta$-thujone and $\alpha$-thujone, camphor, and borneol), sesquiterpene lactones, flavonoids, and phenolic acids.
  • Mechanism of Action: > The primary constituent thujone acts as a potent $GABA_A$ receptor antagonist in the central nervous system, blocking GABA-mediated inhibitory pathways. While this induces anthelmintic properties by paralyzing or killing intestinal parasites, it also drives systemic neurological excitation, smooth muscle contraction, and hyperemic flow within the pelvic basin to stimulate uterine contractions.

Clinical Applications & Indications

  • Primary Indications: Short-term, carefully monitored treatment of intestinal helminthiasis (parasitic worms); functional amenorrhea (delayed menses) with absolute certainty of non-pregnancy. Note: Modern internal use is minimized in favor of safer agents.
  • Secondary Indications: Externally as a concentrated wash or poultice for scabies, pediculosis (lice), fleas, and sprains.
  • Modern Clinical Evidence: Toxicity studies clarify the narrow therapeutic window of thujone-heavy chemotypes, shifting the focus of modern clinical phytotherapy heavily toward external applications and toxicology boundaries.

Preparation, Dosing & Extraction Matrix

  • Optimal Menstruum & Extraction Guidelines: Internal use of the essential oil is strictly prohibited. Standard herbal preparations are restricted to brief, low-dose infusions to extract water-soluble bitter principles while minimizing highly toxic, concentrated thujone spikes.

Standard Dosage Parameters

Delivery MethodStandard Clinical DosageFrequency / Administration
Infusion (Leaf/Flower)0.5–1.0 gram of dried herbSteeped 5–10 mins covered; maximum 1–2x daily for no more than 1 week
Tincture (1:5, 45% EtOH)0.5–1.5 mL (Low dose only)Administered with extreme clinical vigilance
Topical Wash / Infusion1–2 tbsp of herb per pint of waterDecocted, strained, and applied to intact skin as an insect/parasite wash

Safety Profile, Contraindications & Drug Interactions

  • Contraindications: Absolutely contraindicated during pregnancy (potent abortifacient), lactation, and for pediatric patients. Contraindicated in individuals with active liver or kidney disease.
  • Side Effects & Toxicity Thresholds: Ingestion of excessive doses or the essential oil triggers severe toxicity, presenting with violent epileptiform convulsions, uterine hemorrhaging, severe gastroenteritis, tachycardia, hepatorenal failure, and death.
  • Pharmaceutical Cross-Interactions: * Enzyme Alterations: Modulates hepatic detoxification profiles unpredictably.
    • Additive Pathways: Lowers the seizure threshold; severely compromises or antagonizes anti-epileptic/anticonvulsant pharmaceuticals.

References

  1. Grieve, M. A Modern Herbal.
  2. American Herbal Products Association (AHPA) Botanical Safety Handbook.
  3. Hold, K. M., et al. (2000). “Alpha-thujone (the active component of absinthe) choosing the $GABA_A$ receptor as a principal site of action.” Proceedings of the National Academy of Sciences.